Traxion Sab De Cv Ord Shs GRPOF

RE:RE:RE:RE:RE:Yes volume is low

[Ripsanddips]

av8tor42 wrote:

LeafRider wrote: Maybe it has a lot to do with us being so focused into the Canadian market. Sure we're doing well to link everything through US connections and US opportunities for partnerships and licensing deals, but the huge money is the US market, if Tetra was a US company operating in the US on what we're doing right now you're probably right we would be well over a $1. Everyone wants to see the SP double overnight, that isn't reality unless we sign a huge partnering deal with someone for another PPP005 or PPP006, who knows what actually comes to be in the 12months, I'll be around to find out, but I agree, lets hang out at a price point that fits what's in the pipeline and what will be forecasted... Sales are coming that's all that matters. Once this product hits Aphria we have little idea how well it will actually do, but I'm hopeful patients will get on board.

Huge money in the US market...lol...look what Aphria i9s going through

Big diff between investing in an mmj Company and running clinical trials 

TBP went through the TSX ringer and came out clean 


thee other companies listed first and then acquired the assets after the fact 

stop spreading your BS